Abdulmecit AFŞİN, Arif SÜNER, Yusuf HOŞOĞLU, Ayşe HOŞOĞLU

Evaluation of the right and left ventricular functions of patients that recovered from COVID‑19 at home

Objective: Coronavirus disease 2019 (COVID-19) is an infection that can involve various systems and organs, as well as the cardiovascular system. There are several reports in the literature on cardiac involvement in COVID-19 patients who are hospitalized. Therefore, the current research was designed to determine whether cardiac involvement occurred in COVID-19 patients at home. Methods: The current research included 30 patients with a positive COVID-19 PCR test but no hospitalization and recovery at home, and also 30 healthy volunteers. All participants underwent routine and transthoracic echocardiographic exams. The left and right ventricular diameters and functions were examined using two-dimensional echocardiography. M-mode imaging was used to assess tricuspid annular plane systolic excursion (TAPSE) and mitral annular plane systolic excursion (MAPSE). In addition, the tissue Doppler images of the patients were recorded. Results: In the COVID-19 group, 53% of the patients were male, and the mean age was 35.6 years (±7.6). The control group consisted of 57% males, and the mean age was 35.1 years (±6.9). The right and left ventricular diameters, systolic pulmonary artery pressure, and TAPSE and MAPSE values were similar in the two groups. In both groups, the tricuspid lateral annular systolic velocity (S’ tricuspid) values were in the normal reference range. However, the S’ tricuspid value was statistically lower in the COVID-19 group than in the control group (13 [14-11] vs. 14 [15-13]; p=0.010). Conclusion: In this study, cardiac functions did not significantly differ between patients with mild COVID-19 infection and the control group.

Anahtar Kelimeler:

Coronavirus disease 2019, home recovery, cardiac involvement, ventricular function

Evaluation of the right and left ventricular functions of patients that recovered from COVID‑19 at home

Keywords:

Coronavirus disease 2019, home recovery, cardiac involvement, ventricular function,

PDF

___

1. Görmeli Kurt N, Çamcı M. COVID-19 and Other Viral Pneumonias. Dicle Med J. 2021; 48: 40-46.
2. Kwenandar F, Japar KV, Damay V, et al. Coronavirus disease 2019 and cardiovascular system: A narrative review. Int J Cardiol Heart Vasc. 2020; 29: 100557.
3. Chang WT, Toh HS, Liao CT, et al. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci. 2021; 361: 14-22.
4. Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020; 21: 949-58.
5. Szekely Y, Lichter Y, Taieb P, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020; 142: 342-53.
6. Jarori U, Maatman TK, Maatman B, et al. Mitral Annular Plane Systolic Excursion: An Early Marker of Mortality in Severe COVID-19. J Am Soc Echocardiogr. 2020; 33: 1411-13.
7. Modin D, Møgelvang R, Andersen DM, Biering- Sørensen T. Right Ventricular Function Evaluated by Tricuspid Annular Plane Systolic Excursion Predicts Cardiovascular Death in the General Population. J Am Heart Assoc. 2019; 8: e012197.
8. Schmid E, Hilberath JN, Blumenstock G, et al. Tricuspid annular plane systolic excursion (TAPSE) predicts poor outcome in patients undergoing acute pulmonary embolectomy. Heart Lung Vessel. 2015; 7: 151-58.
9. Lassen MCH, Skaarup K G, L ind J N, e t a l. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study. ESC Heart Fail. 2020; 7: 4189- 97.
10. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29: 277-314.
11. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1-39.
12. Catena C, Colussi G, Bulfone L, et al. Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery. J Am Soc Echocardiogr. 2020; 20: 30666.
13. Wu VC, Takeuchi M. Echocardiographic assessment of right ventricular systolic function. Cardiovasc Diagn Ther. 2018; 8: 70-9.
14. Li Y, Li H, Zhu S, et al. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc Imaging. 2020; 13: 2287-99.
15. Martha JW, Pranata R, Wibowo A, et al. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis. Int J Infect Dis. 2021; 105: 351-56.
16. Pagnesi M, Baldetti L, Beneduce A, et al. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020; 106: 1324-31.
17. Ozer PK, Govdeli EA, Baykiz D, et al. Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19. Int J Cardiovasc Imaging. 2021; 11: 1-11.
18. Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020; 5: 831-40.
19. Tudoran M, Tudoran C, Lazureanu VE, et al. Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology. J. Pers. Med. 2021; 11: 225.
20. Sechi LA, Colussi G, Bulfone L, et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol. 2021; 22: 1-10.